Impact of an Innovative Childhood TB Diagnostic Approach Decentralized to District Hospital and Primary Health Care Levels on Childhood Tuberculosis Case Detection and Management in High Tuberculosis Incidence Countries (TB-Speed Decentralisation)
1 other identifier
interventional
3,106
5 countries
49
Brief Summary
The TB-Speed Decentralisation study aims to increase childhood Tuberculosis (TB) case detection at district hospital (DH) and Primary health Care (PHC) levels using adapted and child-friendly specimen collection methods, i.e. Nasopharyngeal Aspirate (NPA) and stool samples, sensitive microbiological detection tests (Ultra) close to the point-of-care (Omni/G1(Edge)), reinforced training on clinical diagnosis, and standardized CXR quality and interpretation using digital radiography. The TB-Speed Decentralisation study will evaluate the impact of an innovative patient care level diagnostic approach deployed at DH and PHC levels, namely the DH focused and the PHC focused decentralization strategies. This is aimed at, improving case detection in 6 high TB incidence in low/moderate resource countries: Cambodia, Cameroon, Côte d'Ivoire, Mozambique, Sierra Leone, and Uganda, and compare effectiveness and cost-effectiveness of the two different decentralization approaches. The hypothesis is that, in countries with high and very high TB incidence (100-299 and ≥300 cases/100,000 population/year, respectively), a systematic approach to the screening for and diagnosis of TB in sick children presenting to the health system will increase childhood TB case detection, especially PTB, which represents the majority of the disease burden (\>75% of case). The study also hypothesizes that sputum collection using battery-operated suction machines and microbiological TB diagnosis using Omni/G1 (Edge) can be decentralized to PHC level, thus enabling TB diagnosis and treatment in children at PHC level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2020
Typical duration for not_applicable
49 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2019
CompletedFirst Posted
Study publicly available on registry
July 31, 2019
CompletedStudy Start
First participant enrolled
March 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedMarch 26, 2025
February 1, 2025
2.1 years
June 6, 2019
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Children diagnosed with TB
Proportion of TB cases detected among sick children routinely attending outpatient services before and after the intervention
Day 0
Secondary Outcomes (17)
TB case detection
Month 6
TB screening in outpatient children - 1
Day 7
TB screening in outpatient children - 2
Day 7
Feasibility of implementing the different diagnostic approach components - 1
Day 7
Feasibility of implementing the different diagnostic approach components - 2
Day 7
- +12 more secondary outcomes
Study Arms (2)
District Hospital focused decentralization strategy
EXPERIMENTALIn this strategy, the patient care level innovative childhood TB diagnostic approach will be implemented at the DH level. PHCs in this district, will only conduct systematic TB screening.
Primary Health Center focused decentralization strategy
EXPERIMENTALIn this strategy, the patient care level innovative childhood TB diagnostic approach will be done at the PHC.
Interventions
The patient care level TB diagnostic approach consists of systematic TB screening, clinical evaluation, NPA and stool or sputum testing using Xpert Ultra, and optimised CXR reading will be implemented at DH and PHC levels
Eligibility Criteria
You may qualify if:
- Sick children seeking care at Oupatient Department of District Hospital or Primary Health Center
- Age \<15 years
You may not qualify if:
- \- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (59)
Angroka Rh
Angroka, Cambodia
Taphem Hc
Angroka, Cambodia
Tropang Andert Hc
Angroka, Cambodia
Batheay Rh
Batheay, Cambodia
Choeung Chnok Hc
Batheay, Cambodia
Tumnub Hc
Batheay, Cambodia
Nhaeng Nhang Hc
Nhaeng Nhang, Cambodia
KUS HC
Phumĭ Kŭs, Cambodia
Phaav HC
Ph’av, Cambodia
Sambour Hc
Sambour, Cambodia
Csi Messngssang
Bafia, Cameroon
HD BAFIA
Bafia, Cameroon
Csi Balamba Bafia
Balamba, Cameroon
Cma Batchenga
Batchenga, Cameroon
Cma Bokito Bafia
Bokito, Cameroon
Csi Essong
Essong, Cameroon
Cma Kiiki Bafia
Kiiki, Cameroon
Cma Fomakap
Obala, Cameroon
Csi Ngogo
Obala, Cameroon
Obala Hosp
Obala, Cameroon
Dr Banteapleu
Banteapleu, Côte d’Ivoire
Csu Dakpadou
Dakpadou, Côte d’Ivoire
Csr Daleu
Daleu, Côte d’Ivoire
H G de Danane
Danané, Côte d’Ivoire
Csu Kouan-Houle
Kouan Houlé, Côte d’Ivoire
Csu Mahapleu
Mahapleu, Côte d’Ivoire
Csr Medon
Médon, Côte d’Ivoire
CMS SAGO
Sago, Côte d’Ivoire
Dr de Sahoua
Sahoua, Côte d’Ivoire
H G Sassandra
Sassandra, Côte d’Ivoire
Chiaquelane
Chiaquelane, Mozambique
Chibonzane
Chibonzane, Mozambique
Chidenguele
Chidenguele, Mozambique
Chalocuane
Chokwé, Mozambique
HOKWE
Chokwé, Mozambique
Hosp Rural Chokwe
Chokwé, Mozambique
MACUACUA
Macuácua, Mozambique
Hospital Rural de Manjacaze
Manjacaze, Mozambique
Laranjeira
Manjacaze, Mozambique
Babara Chc
Babara, Sierra Leone
Bo Govt Hosp
Bo, Sierra Leone
New Police barracks
Bo, Sierra Leone
Gbinti Chc
Gbinti, Sierra Leone
Gerihun Chc
Gerihun, Sierra Leone
Koribondo Chc
Koribondo, Sierra Leone
Mange Chc
Mange, Sierra Leone
Njala University Chc
Njala, Sierra Leone
Petifu Chc
Petifu, Sierra Leone
Port Loko Govt Hosp
Port Loko, Sierra Leone
Buyamba Hc Iii
Buyamba, Uganda
Kambuga Hospital
Kambuga, Uganda
Kanungu Hciv
Kanungu, Uganda
Kanyantorogo Hciii
Kanyantorogo, Uganda
Lwamaggwa Hc Iii
Lwamaggwa, Uganda
Lwanda Hc Iii
Lwanda, Uganda
St Bernards Manya Hc Iii
Manya, Uganda
Matanda Hciii
Matanda, Uganda
Nyamirama HC III
Nyamirama, Uganda
Rakai Hospital
Rakai, Uganda
Related Publications (3)
Joshi B, De Lima YV, Massom DM, Kaing S, Banga MF, Kamara ET, Sesay S, Borand L, Taguebue JV, Moh R, Khosa C, Breton G, Mwanga-Amumpaire J, Bonnet M, Wobudeya E, Marcy O, Orne-Gliemann J; TB-Speed Decentralization study group. Acceptability of decentralizing childhood tuberculosis diagnosis in low-income countries with high tuberculosis incidence: Experiences and perceptions from health care workers in Sub-Saharan Africa and South-East Asia. PLOS Glob Public Health. 2023 Oct 11;3(10):e0001525. doi: 10.1371/journal.pgph.0001525. eCollection 2023.
PMID: 37819919BACKGROUNDd'Elbee M, Harker M, Mafirakureva N, Nanfuka M, Huyen Ton Nu Nguyet M, Taguebue JV, Moh R, Khosa C, Mustapha A, Mwanga-Amumpere J, Borand L, Nolna SK, Komena E, Cumbe S, Mugisha J, Natukunda N, Mao TE, Wittwer J, Benard A, Bernard T, Sohn H, Bonnet M, Wobudeya E, Marcy O, Dodd PJ; TB-Speed Health Economics Study Group. Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study. EClinicalMedicine. 2024 Mar 21;70:102528. doi: 10.1016/j.eclinm.2024.102528. eCollection 2024 Apr.
PMID: 38685930DERIVEDWobudeya E, Nanfuka M, Ton Nu Nguyet MH, Taguebue JV, Moh R, Breton G, Khosa C, Borand L, Mwanga-Amumpaire J, Mustapha A, Nolna SK, Komena E, Mugisha JR, Natukunda N, Dim B, de Lauzanne A, Cumbe S, Balestre E, Poublan J, Lounnas M, Ngu E, Joshi B, Norval PY, Terquiem EL, Turyahabwe S, Foray L, Sidibe S, Albert KK, Manhica I, Sekadde M, Detjen A, Verkuijl S, Mao TE, Orne-Gliemann J, Bonnet M, Marcy O; TB-Speed Decentralisation study group. Effect of decentralising childhood tuberculosis diagnosis to primary health centre versus district hospital levels on disease detection in children from six high tuberculosis incidence countries: an operational research, pre-post intervention study. EClinicalMedicine. 2024 Mar 21;70:102527. doi: 10.1016/j.eclinm.2024.102527. eCollection 2024 Apr.
PMID: 38685921DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Marcy, PhD
University of Bordeaux
- PRINCIPAL INVESTIGATOR
Maryline Bonnet, PhD
Institut de Recherche pour le Developpement
- PRINCIPAL INVESTIGATOR
Eric Wobudeya, PhD
MU-JHU Care Ltd
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2019
First Posted
July 31, 2019
Study Start
March 7, 2020
Primary Completion
March 31, 2022
Study Completion
March 31, 2022
Last Updated
March 26, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share